Capricor Therapeutics, Inc. (CAPR)
NASDAQ·Healthcare·Biotechnology
$6.27
+2.95%
Mkt Cap $353.26M
Analyst Ratings
Buy
4
Hold
4
Sell
0
Price Target (22 analysts)
$12.70
Range $3.50 – $25.00
Implied Upside
+102.6%
Consensus $12.70 vs current $6.27
NASDAQ·Healthcare·Biotechnology
$6.27
+2.95%
Mkt Cap $353.26M
Buy
4
Hold
4
Sell
0
Price Target (22 analysts)
$12.70
Range $3.50 – $25.00
+102.6%
Consensus $12.70 vs current $6.27